Fabius,
This is what IPCI's website says in regards to IP. It is clear they say this list belongs to us(IPCI). There is no question that IP developed with IPCI's money/tools/resources are the sole property of IPCI. Odidi will be laughed out of the courtroom if he tries to say he has some ownership. He was paid very well by IPCI in terms of salaries/bonuses to develop IPCI's IP/patents/products/etc. He has no grounds to claim ownership:
Intellectual Property
Proprietary rights are an important aspect of our business. These include know-how, trade secrets and patents.
Patents which relate to and protect various aspects of our Hypermatrix™ family of drug delivery technologies include the following United States, Japanese, Chinese, Indian, Canadian and European patents which have been issued to us:
Country
Issue Date
Issue No.
Title
U.S.A. Oct 31, 2017 9,801,939 Compositions and Methods for Reducing Overdose
U.S.A. July 11, 2017 9,700,516 Compositions and Methods for Reducing Overdose
U.S.A. July 11, 2017 9,700,515 Compositions and Methods for Reducing Overdose
U.S.A. Dec 20, 2016 9,522,119 Compositions and Methods For Reducing Overdose
U.S.A. July 14, 2015 9,078,827 Pharmaceutical Composition Having Reduced Abuse Potential
U.S.A. Aug 12, 2014 8,802,139 Proton Pump-Inhibitor-Containing Capsules Which Comprise Subunits Differently Structured For A Delayed Release Of The Active Ingredient
U.S.A. Dec 10, 2013 8,603,520 Oral Multi-functional Pharmaceutical Capsule Preparations of Proton Pump Inhibitors
U.S.A. Mar 12, 2013 8,394,409 Controlled Extended Drug Release Technology
U.S.A. Mar 15, 2011 7,906,143 Controlled Release Pharmaceutical Delivery Device and Process for Preparation Thereof
U.S.A. Dec 28, 2010 7,858,119 Extended Release Pharmaceuticals
U.S.A. Aug 15, 2006 7,090,867 Novel Controlled Release Delivery Device for Pharmaceutical Agents Incorporating Microbial Gum
U.S.A. Oct 5, 2004 6,800,668 Syntactic Deformable Foam Compositions and Methods for Making
U.S.A. Nov 25, 2003 6,652,882 Controlled Release Formulation Containing Bupropion
U.S.A. Aug 19, 2003 6,607,751 Novel Controlled Release Delivery Device for Pharmaceutical Agents Incorporating Microbial Gum
U.S.A. Nov 12, 2002 6,479,075 Pharmaceutical Formulations for Acid Labile Substances
U.S.A. Oct 2, 2001 6,296,876 Pharmaceutical Formulations for Acid Labile Substances
Japan Aug 28, 2015 5,798,293 Pharmaceutical Composition Having Reduced Abuse Potential
Japan Jan 17, 2014 5,457,830 Controlled Release Delivery Device Comprising An Organosol Coat
Japan Aug 8, 2014 5,592,547 Drug Delivery Composition
Japan Aug 30, 2013 5,349,290 Drug Delivery Composition
India Feb 10, 2015 265,141 Pharmaceutical Composition Having Reduced Abuse Potential
Europe Nov 26, 2014 2,007,360 Controlled Release Delivery Device Comprising an Organosol Coat
Canada May 26, 2015 2,579,382 Controlled Release Composition Using Transition Coating, And Method Of Preparing Same
Canada Jan 28, 2014 2,571,897 Controlled Extended Drug Release Technology
Canada Apr 8, 2014 2,576,556 Disintegrant Assisted Controlled Release Technology
Canada Mar 11, 2014 2,648,280 Controlled Release Delivery Device Comprising an Organosol Coat
Canada Jun 19, 2012 2,626,558 Pharmaceutical Composition having Reduced Abuse Potential
Canada Sep 25, 2012 2,529,984 Oral Multi-Functional Pharmaceutical Capsule Preparations of Proton Pump Inhibitors
Canada Feb 22, 2011 2,459,857 Combinatorial Type Controlled Release Drug Delivery Device
Canada Mar 15, 2005 2,435,276 Syntactic Deformable Foam Compositions and Methods for Making
Canada Nov 29, 2016 2,910,865 Compositions and Methods For Reducing Overdose
China May 11, 2016 ZL200780019665.5 Drug Delivery Composition
China Nov 25, 2015 ZL200780025611.X Pharmaceutical Composition Having Reduced Abuse Potential
In addition to these issued patents, we have several U.S. patent applications, and corresponding foreign applications pending, including Patent Cooperation Treaty - national stage processing and entry applications, relating to various aspects of our HyperMatrix™ drug delivery technologies, including methods and compositions for coating of tablets and beads, compositions incorporating disintegrants to assist in controlled release, compositions incorporating multiple drug actives, and compositions directed to classes of drug actives designed as therapies for specific indications and compositions intended to enhance deterrence of willful abuse of narcotic compositions.
© 2018 Intellipharmaceutics International Inc. All Rights Reserved.
